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Abstract 
Background: Both carotid and lower limb atherosclerosis are associated with increased cardiovascular and cerebro‑
vascular risks. However, it is still unclear whether the concomitant presence of carotid and lower extremity atheroscle‑
rosis further increases the cardiovascular and cerebrovascular risks. Therefore, our aim is to investigate whether the 
coexistence of carotid and lower extremity atherosclerosis was associated with higher cardiovascular and cerebrovas‑
cular risks in patients with type 2 diabetes.
Methods: This cross‑sectional study was performed in 2830 hospitalized patients with type 2 diabetes. Based on 
carotid and lower limb Doppler ultrasound results, the patients were divided into three groups including 711 sub‑
jects without atherosclerosis, 999 subjects with either carotid or lower limb atherosclerosis, and 1120 subjects with 
both carotid and lower limb atherosclerosis. And we compared the clinical characteristics and prevalence of both 
cardio‑cerebrovascular events (CCBVEs) and self‑reported cardio‑ cerebrovascular diseases (CCBVDs) among the three 
groups.
Results: After adjusting for age, sex, and duration of diabetes, there were significant increases in the prevalence of 
both CCBVEs (3.8 vs. 11.8 vs. 26.4 %, p < 0.001 for trend) and self‑reported CCBVDs (6.9 vs. 19.9 vs. 36.5 %, p < 0.001 
for trend) across the three groups (diabetics without atherosclerosis, diabetics with either carotid or lower limb 
atherosclerosis, and diabetics with both carotid and lower extremity atherosclerosis). A fully adjusted logistic regres‑
sion analysis also revealed that compared with those without atherosclerosis, those with either carotid or lower limb 
atherosclerosis had higher risk of CCBVEs (OR 1.724, 95 % CI 1.001–2.966) and self‑reported CCBVDs (OR 1.705, 95 % 
CI 1.115–2.605), and those with concomitant presence of carotid and lower extremity atherosclerosis had the high‑
est risk of CCBVEs (OR 2.869, 95 % CI 1.660–4.960) and self‑reported CCBVDs (2.147, 95 % CI 1.388–3.320)(p < 0.001 for 
trend in CCBVEs and p = 0.002 for trend in CCBVDs, respectively).
Conclusions: Either carotid or lower limb atherosclerosis was obviously related to increased cardio‑cerebrovascular 
risk in type 2 diabetes. The concomitant presence of carotid and lower extremity atherosclerosis further increased 
cardio‑cerebrovascular risk in patients with type 2 diabetes. The combined application of carotid and lower extremity 
ultrasonography may help identify type 2 diabetics with higher cardio‑cerebrovascular risk.
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Background
Epidemiological and clinical studies frequently indicate 
that people with type 2 diabetes have elevated risk to get 
a number of serious atherosclerotic vascular problems, 
especially cardio-cerebrovascular diseases (CCBVDs) [1–
5]. For example, a prospective observational study dis-
played that each 1 % increase in the glycated hemoglobin 
level is associated with an increase of 14 % in the risk of 
myocardial infarction [6]. Moreover, in the Multiple Risk 
Factor Intervention Trial of 347,978 men, diabetic men 
were three times more likely to develop a stroke than 
nondiabetic ones [7]. Therefore, early identification of 
subjects with high cardio-cerebrovascular risk is quite 
crucial in type 2 diabetes.
Several studies have demonstrated that indices such 
as systemic atherosclerosis, cardio-ankle vascular index, 
ankle brachial index and pulse wave velocity are closely 
related to cardiovascular risk in diabetic populations 
[8–12]. However, accurate measurement of above index 
requires specialized training and demands a tedious and 
long procedure, and thus they probably could not be 
widely used in routine clinical practice especially remote 
areas in China.
Numerous Studies have demonstrated that artery 
intima-media thickness (IMT) and plaques in carotid, 
femoral are associated with increased risk of cardio-cer-
ebrovascular events (CCBVEs) and CCBVDs [13–19]. 
For example, the Osaka Follow-Up Study demonstrated 
that every 1-SD increment in carotid IMT was obviously 
associated with a 1.57 hazard ratio in the cardiovascular 
events [20]. And most importantly, two prospective data 
indicated that evaluations of plaques provided better pre-
diction for incident cardiovascular events than assess-
ments of IMT in patients with stable angina and patients 
with end-stage renal disease [21, 22]. Collado et  al. 
[23] recently also reported that the presence of carotid 
plaque, especially, calcified plaque, were predictors of 
new cardiovascular events and cardiovascular mortality, 
but carotid IMT was not in hemodialysis patients.
However, in some studies, no significant relationship 
was observed between IMT, plaque and CCBVEs, CCB-
VDs after adjusting for other vascular risk factors [24, 
25]. For example, during Seven-Year Follow-Up, Yuk 
et  al. [25] found that coronary artery disease patients 
with either carotid plaque or thick IMT had higher inci-
dence and prediction rates of stroke, but this was not sta-
tistically significant after being adjusted in multivariate 
analysis. Furthermore, in comparison with carotid and 
femoral plaques, very few studies are available regard-
ing the correlation between the concomitant carotid and 
lower limb atherosclerosis and CCBVEs and CCBVDs.
Therefore, the purposes of our study were to determine 
whether the presence of either carotid or lower limb ath-
erosclerosis increases cardiovascular and cerebrovascular 
risks indicated by CCBVEs and self-reported CCBVDs, 
and further to verify whether the concomitant presence 
of carotid and lower extremity atherosclerosis further 
increases the cardio-cerebrovascular risk independent of 




Our present study was cross-sectional and the data 
partly came from our previous studies [26–33]. That is, 
3598 patients with type 2 diabetes mellitus hospitalized 
for either comprehensive diabetic complications screen-
ing or poor blood glucose control in our department 
were continuously observed from January 2007 to June 
2009. And 768 subjects were eliminated as the following 
reasons: incomplete physical examination and clinical 
parameters, and lack of carotid or lower limb ultrasound 
examinations. Ultimately, 2830 participants joined in 
our following analysis, including 1246 males and 1584 
females.
We recorded all participants’ information, such as 
duration of diabetes (DD), smoking and drinking hab-
its, the history of hypertension, the administered drugs 
including insulin or insulin analogues (IIAs), lipid-low-
ering drugs (LLDs), antihypertensive agents (AHAs) 
and anti-platelet agents (APAs), cardiovascular events 
(CVEs), cerebrovascular events (CBVEs), CCBVEs, self-
reported cardiovascular diseases (CVDs), self-reported 
cerebrovascular diseases (CBVDs), and self-reported 
CCBVDs. Our current study was approved by the eth-
ics committee of Shanghai Jiao Tong University Affiliated 
Sixth People’s Hospital, and written informed consent 
was obtained from all participants.
Physical and laboratory examinations
The physical and laboratory examinations used in our 
present study have been clearly described in our previ-
ous studies [26–33]. Briefly, height, weight, waist cir-
cumference, hip circumference, and blood pressure were 
measured according to standard protocols. The body 
mass index (BMI) and the waist-to-hip ratio (WHR) were 
Keywords: Type 2 diabetes, Carotid atherosclerosis, Lower limb atherosclerosis, Cardio‑cerebrovascular events, Self‑
reported cardio‑cerebrovascular diseases
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based on the corresponding formula to calculate [26]. 
Blood samplings were performed to test total cholesterol 
(TC), total triglycerides (TTG), high-density lipoprotein 
cholesterol (HDL-C), low-density lipoprotein choles-
terol (LDL-C), glycosylated hemoglobin A1C (HbA1c), 
fasting plasma glucose(FPG), 2-h postprandial plasma 
glucose (2h PPG), fasting C-peptide(FCP), 2-h post-
prandial C-peptide (2h PCP), alanine aminotransferase 
(ALT), creatinine (Cr), serum uric acid (SUA), C-reactive 
protein(CRP). The 24-h urinary albumin excretion (UAE) 
was calculated as the mean from three separate urine 
samples. The estimated glomerular filtration rate (eGFR) 
was calculated using the simplified MDRD formula: 
eGFR  =  186.3  ×  (Serum creatinine)−1.154  ×  (age)−0.203 
(×0.742 if female).
Ultrasonography examinations
Doppler ultrasonography examinations of carotid and 
lower limb arteries, involving in the measurement of 
intima-media thickness, atherosclerotic plaque and ste-
nosis, have been previously described in details [26, 27, 
30, 32]. That is, the ultrasonographic examination was 
carried out by three experienced ultrasonographers 
using a machine Acuson Sequoia 512 with a probe of 
5–13-MHz  MHz according to a standardized protocol. 
After the participants had kept in the supine position 
for 5 min, the transducer was successively placed on the 
neck and lower limbs to manifest blood vessel imaging 
and blood flow characteristics. At each location, IMT 
and atherosclerotic plaques were recorded. Carotid 
arteries were examined bilaterally at the levels of the 
common carotid arteries, the bifurcation, the external 
carotid arteries, and the internal carotid arteries from 
transverse and longitudinal orientations. Lower limb 
arteries were evaluated bilaterally at the levels of the 
seven locations: common femoral artery, profunda fem-
oris artery, superficial femoral artery, popliteal artery, 
anterior tibial artery, posterior tibial artery and peroneal 
artery. The measurement reproducibilities of the above 
atherosclerotic lesions have also been indicated previ-
ously [27, 32].
Diagnostic criteria
Dyslipidemia was defined as TG  ≥  1.7  mmol/L, or 
LDL-C  ≥  3.37  mmol/L, or TC  ≥  5.18  mmol/L, or 
HDL-C < 1.04 mmol/L, or use of LLDs. The definitions 
of CVEs, CBVEs, CCBVEs, carotid and lower extremity 
atherosclerosis were carried out referring to our previous 
studies [26, 28, 31]. Briefly, CVEs were defined based on 
a history of myocardial infarction, angina, angioplasty, 
or coronary artery bypass surgery. CBVEs were defined 
based on a history of transient ischemic attack, ischemic, 
or hemorrhagic stroke. CCBVEs were defined based on 
histories of CVEs and/or CBVEs. According to the Man-
nheim consensus [34], atherosclerotic plaques were 
defined as focal structures encroaching into the arterial 
lumen of 0.5 mm or 50 % of the surrounding IMT value 
or IMT of >1.5 mm. The definitions of carotid and lower 
limb arteriosclerosis were based on our previous stud-
ies [26, 27]. Briefly, carotid atherosclerosis was defined 
as the presence of carotid arterial atherosclerotic plaque 
in any of bilateral carotid artery segments including the 
common, the bifurcation, the external, and the internal 
carotid arteries. Lower extremity atherosclerosis was 
defined as the presence of lower extremity arterial ath-
erosclerotic plaque in any of bilateral lower extremity 
artery segments including the common, the profunda 
and the superficial femoral arteries, and popliteal arter-
ies, anterior tibial arteries, posterior tibial arteries, and 
peroneal arteries.
Self reported CVDs were defined as reporting of one 
or more of the following conditions: coronary artery 
disease, congestive heart failure, or CVEs. Self reported 
CBVDs were defined as reporting of one or more of the 
following conditions: radiologic findings of cerebrovas-
cular diseases or CBVEs. Self-reported CCBVDs were 
defined as having self-reported CVDs and/or CBVDs.
Statistical analysis
SPSS 15.0 was performed to analyze the data. Data were 
represented as either mean ± SD or median or percent-
age. One-way ANOVA with LSD was used to calculate 
group comparisons for continuous variables with nor-
mal distribution. Kruskal–Wallis test was conducted for 
continuous variables with non-normal distribution. Chi 
squared statistical analysis was used for comparisons in 
categorical variables. Binary multiple regression analy-
sis was conducted to identify the correlations between 
the concomitant presence of carotid and lower extrem-
ity atherosclerosis and CCBVEs, self-reported CCB-
VDs. p  <  0.05 (two-sided) was considered as statistical 
significance.
Results
Clinical and biochemical characteristics of the study 
subjects
The patients were divided into three groups including 
subjects without atherosclerosis, with either carotid or 
lower limb atherosclerosis, and with concomitant carotid 
and lower limb atherosclerosis. Table 1 displays the clini-
cal and laboratory characteristics of the studied subjects 
among the three groups. Age, sex, DD, alcohol, preva-
lence of hypertension and dyslipidemia, proportion of 
use of IIAs, LLDs, AHAs and APAs, systolic blood pres-
sure (SBP), diastolic blood pressure (DBP), TC, LDL-C, 
2h C-P, Cr, UAE and SUA were significantly different 
Page 4 of 12Li et al. Cardiovasc Diabetol  (2016) 15:43 
among the three groups when age and sex were examined 
(all p < 0.05).
Characteristics of CCBVEs and self‑reported CCBVDs of the 
whole subjects
Characteristics of CCBVEs and self-reported CCB-
VDs stratified by sex, age and DD in all participants are 
shown in Figs. 1 and 2. Figures 1a and 2a demonstrated 
that there was no sex-related significant difference in 
the prevalence of CCBVEs and self-reported CCB-
VDs, respectively. However, a remarkable increase with 
age and DD was successively found in the prevalence 
of CCBVEs and CCBVDs among the whole patients 
(Figs.  1b, d, and  2b, d). Additionally, the prevalence of 
isolated CBVEs (12.5 %) was notably higher than that of 
isolated CVEs (2.1  %) and combined CVEs and CBVEs 
(0.9 %) in type 2 diabetes. The same trend was found for 
self-reported cardiovascular and cerebrovascular diseases 
(11.8 % for isolated CBVDs, 8.4 % for isolated CVDs, and 
3.1  % for combined CVDs and CBVDs, respectively) in 
type 2 diabetes (Figs. 1c and 2c).
Comparison of IMT in carotid and femoral among the three 
groups
After controlling for age, sex and DD, a comparison of 
IMT in carotid and femoral (CIMT and FIMT) among 
Table 1 Characteristics of the study subjects
Values are presented as mean ± SD, median with interquartile range, or percentages
a Non-normal distribution of continuous variables
p value: The p values were not adjusted for age and sex for the trend
* p value: The * p value were adjusted by sex and age for the trend
Variables Without AS  
(n = 711)
With either carotid or  
lower limb AS (n = 999)
With both carotid and  
lower limb AS (n = 1120)
p value *p value
Age (months) 49 ± 11 60 ± 10 67 ± 10 <0.001 <0.001
Male (n,  %) 325 (45.7 %) 446 (44.6 %) 475 (42.4 %) 0.340 <0.001
DD (months)a 48 (3–96) 84 (24–132) 120 (48–168) <0.001 <0.001
Smoking (n,  %) 226 (31.79 %) 291 (29.13 %) 281 (25.09 %) 0.007 0.612
Alcohol (n,  %) 115 (16.17 %) 171 (17.12 %) 142 (12.68 %) 0.014 0.036
Hypertension (n,  %) 256 (36.00 %) 521 (52.20 %) 742 (66.20 %) <0.001 <0.001
Dyslipidemia (n,  %) 546 (76.8 %) 729 (73.0 %) 857 (76.5 %) 0.041 0.001
IIAs (n,  %) 486 (68.4 %) 687 (68.8 %) 849 (75.8 %) <0.001 <0.001
LLD (n,  %) 189 (26.6 %) 292 (29.2 %) 402 (35.9 %) <0.001 <0.001
AHAs (n,  %) 224 (31.5 %) 479 (47.9 %) 692 (61.8 %) <0.001 <0.001
APAs (n,  %) 96 (13.5 %) 534 (53.5 %) 827 (73.8 %) <0.001 <0.001
BMI (kg/m2) 24.97 ± 3.48 24.92 ± 3.41 24.78 ± 3.43 0.476 0.888
WHR (cm) 0.91 ± 0.06 0.91 ± 0.06 0.92 ± 0.07 0.004 0.206
SBP (mmHg) 126 ± 15 132 ± 17 136 ± 18 <0.001 <0.001
DBP (mmHg) 80 ± 10 80 ± 10 80 ± 10 0.448 0.006
TC (mmol/l) 4.72 ± 1.14 4.72 ± 1.13 4.74 ± 1.15 0.943 <0.001
TTG (mmol/l)a 1.57 (1–2.48) 1.39 (0.97–2.12) 1.39 (1–1.96) <0.001 0.456
HDL‑C (mmol/l) 1.09 ± 0.32 1.13 ± 0.3 1.12 ± 0.3 0.018 0.120
LDL‑C (mmol/l) 3.07 ± 0.94 3.09 ± 0.9 3.15 ± 1.01 0.148 <0.001
HbA1C (%) 9.22 ± 2.36 9.05 ± 2.36 9.12 ± 2.46 0.346 0.290
FPG (mmol/l)a 8.05 (6.56–10.09) 7.61 (6.17–9.67) 7.55 (6.01–9.39) <0.001 0.572
2h PPG (mmol/l)a 13.76 (10.32–17.18) 13.23 (9.94–16.49) 13.66 (10.22–16.98) 0.246 0.519
FCPa 1.69 (1.03–2.48) 1.68 (1.07–2.44) 1.61 (0.92–2.43) 0.223 0.234
2h PCPa 3.72 (2.17–5.39) 3.81 (2.22–5.47) 3.49 (1.92–5.26) 0.034 0.002
ALT (U/L)a 21 (15–35) 20 (14–31) 17 (12–26) <0.001 0.225
Cr (mmol/l)a 62 (51–73) 67 (56–79) 71 (58–87) <0.001 0.003
UAE (mg/24 h)a 9.8 (6.2–20.1) 11.06 (6.3–25.88) 12.4 (7.1–50) <0.001 0.005
eGFR (ml/min/1.73 m2) m2) 113 (98–132) 99 (84–118) 92 (74–111) <0.001 0.370
SUA (μmol/l)a 308 (252–366) 305 (254–367) 317 (260–383) 0.003 0.034
CRPa 0.99 (0.43–2.26) 1.07 (0.46–2.52) 1.36 (0.6–3.8) <0.001 0.198
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the three groups is shown in Fig.  3. Intriguingly, sig-
nificantly higher value of CIMT was observed across 
the three groups (0.72 ± 0.16 mm, 0.82 ± 0.18 mm and 
0.92 ± 0.21 mm successively for the subjects without ath-
erosclerosis, those with either carotid or lower limb ath-
erosclerosis and those with both carotid and lower limb 
atherosclerosis, p  <  0.001 for trend) (Fig.  3a). The same 
trend was found for FIMT value among the three groups 
(0.70 ± 0.16 mm, 0.82 ± 0.20 mm and 0.91 ± 0.24 mm, 
respectively, p < 0.001 for trend) (Fig. 3b).
Comparison of the prevalence of CCBVEs and self‑reported 
CCBVDs among the three groups
Figure  4 illustrates the comparison of the prevalence of 
CCBVEs and self-reported CCBVDs among the three 
groups. After adjusting for age, sex and DD, there was 
gradual rise in the prevalence of CVEs and self-reported 
CVDs from the group without atherosclerosis, the group 
with either carotid or lower-limb atherosclerosis, to the 
group with concomitant carotid and lower-limb ath-
erosclerosis (p < 0.001 for trend) (Fig. 4a, d). Moreover, 
a remarkable increase in the prevalence of CBVEs and 
self-reported CBVDs was also observed across the three 
groups (p  <  0.001 for trend) (Fig.  4b, e). Likewise, the 
prevalence of CCBVEs and self-reported CCBVDs also 
dramatically rose across the three groups (p < 0.001 for 
trend) after controlling for age, sex and DD (Fig. 4c, f ).
Associations between atherosclerosis and CCBVEs, 
self‑reported CCBVDs
Table  2 presents the association between atherosclero-
sis and CCBVEs in type 2 diabetes. We found that the 
patients with either carotid or lower limb atherosclerosis 
and those with both carotid and lower limb atheroscle-
rosis had 6.405- and 13.841-fold risk of CVEs,1.429- and 
2.218-fold risk of CBVEs, and 1.690- and 2.708-fold risk 
of CCBVEs respectively, compared with the subjects 
without atherosclerosis after adjustment on age, sex, 
smoking, alcohol, DD, MetS, hypertension and CKD 
(Model I). Even after controlling on various clinical indi-
cators (Model II and III), those with either carotid or 
lower limb atherosclerosis and those with the coexistence 
of carotid and lower extremity atherosclerosis still had 
4.742- and 11.306-fold risk of CVEs, 1.389- and 2.092-
fold risk of CBVEs, and 1.724- and 2.869-fold risk of 
CCBVEs, respectively.
Fig. 1 Characteristics of CCBVEs of the entire subjects a The prevalence of CCBVEs stratified by sex after adjusting on age and DD. The p value 
for sex comparison was 0.400. b The prevalence of CCBVEs stratified by age after adjusting on sex and DD. The p value for group comparison was 
<0.001. c The distribution of CCBVEs after adjusting on sex, age and DD. The prevalence of isolated CVEs, isolated CBVEs and combined CVEs and 
CBVEs was successively 2.1, 12.5 and 0.9 %. The p value for group comparison was <0.001. d The prevalence of CCBVEs stratified by duration of 
diabetes after adjusting on sex and age. The p value for group comparison was <0.001
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Table  3 displays the association between atheroscle-
rosis and CCBVDs in type 2 diabetes. After adjustment 
on age, sex, smoking, alcohol, DD, MetS, hypertension 
and CKD (Model I), the patients with either carotid or 
lower limb atherosclerosis and those with both carotid 
and lower limb atherosclerosis had 1.839- and 2.305-fold 
risk of CVDs, 1.515- and 2.123-fold risk of CBVDs, and 
1.587- and 2.023-fold risk of CCBVDs respectively, rela-
tive to those without atherosclerosis. Even after adjusting 
clinical and biochemical parameters (Model II and III), 
the patients with either carotid or lower limb atheroscle-
rosis and those with the coexistence of carotid and lower 
extremity atherosclerosis still had 1.899- and 2.667-fold 
risk of CVDs, 1.582- and 2.114-fold risk of CBVDs, and 
1.705- and 2.147-fold risk of CCBVDs, respectively.
Discussion
Both carotid and femoral atherosclerosis has been sup-
ported as potential predictors of cardiovascular and 
cerebrovascular morbidity and mortality in different 
populations [15, 21, 22]. At present, most studies focused 
on the associations of carotid atherosclerosis with 
cardiovascular and cerebrovascular risks, but investiga-
tions about the relationships between the concomitant 
presence of carotid and lower extremity atherosclerosis 
and cardio-cerebrovascular risk were extremely scarce 
in patient with type 2 diabetes. Therefore, we carried 
out this cross-sectional study to assess the association 
between the concomitant presences of carotid and lower 
extremity atherosclerosis and CCBVEs, self-reported 
CCBVDs in Chinese hospitalized type 2 diabetics. Our 
results strongly indicated that patients with atherosclero-
sis had remarkably higher risk of CCBVEs and self-report 
CCBVDs than those without atherosclerosis even after 
adjustment for other cardiovascular risk factors. Most 
importantly, the coexistence of carotid and lower extrem-
ity atherosclerosis further increases the risk of CCBVEs 
and self-report CCBVDs in type 2 diabetes.
Consistent with other studies [35, 36], we also found 
the prevalence of CCBVEs and self-reported CCBVDs in 
Chinese type 2 diabetic patients successively increased 
with age and duration of diabetes. Several literatures 
reported that men had a higher risk of coronary heart 
disease whereas women had a greater propensity of 
Fig. 2 Characteristics of self‑reported CCBVDs of the whole subjects a The prevalence of CCBVDs stratified by sex after adjusting on age and 
DD. The p value for sex comparison was 0.474. b The prevalence of CCBVDs stratified by age after adjusting on sex and DD. The p value for group 
comparison was <0.001. c The distribution of CCBVDs after adjusting on sex, age and DD. The prevalence of isolated CVDs, isolated CBVDs and both 
CVDs and CBVDs was successively 8.4, 11.8 and 3.1 %. The p value for group comparison was <0.001. d The prevalence of CCBVDs stratified by dura‑
tion of diabetes after adjusting on sex and age. The p value for group comparison was <0.001
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developing stroke [37, 38]. On the contrary, we explored 
that there was no significant gender difference in the 
prevalence of CCBVEs and self-reported CCBVDs, as 
this can be mainly explained by the fact that CCBVEs and 
self-reported CCBVDs included both cardiovascular and 
cerebrovascular events/diseases in our study.
Similar to our previous and other study [30, 32, 39], 
subjects with atherosclerosis had significantly higher val-
ues of CIMT and FIMT than those without atherosclero-
sis. More importantly, we observed that CIMT and FIMT 
values were notably elevated in the patients with con-
comitant presence of carotid and lower extremity athero-
sclerosis than in those with either carotid or lower limb 
atherosclerosis, which suggested that CIMT and FIMT 
closely related to atherosclerosis severity.
Studies revealed that plaques in carotid, femoral arter-
ies were strong predictors of CVEs and self-reported 
CVDs in a variety of populations, including cardiologi-
cal patients, hypertensive patients and general subjects 
[40–43]. For example, Leng et  al. [43] showed that sub-
jects with femoral plaque had significantly 2.2-fold and 
1.7-fold odds of previous ischemic heart disease and 
angina in an older British population. Also, the multi-
ethnic study of atherosclerosis displayed carotid plaque 
independently predict cardiovascular events at 7.8-year 
mean follow-up and improve risk prediction for coronary 
heart disease when added to Framingham risk factors 
[44]. Consistent with these studies, our current study, 
including a sufficiently large number of cases, provides 
further support to the opinion that atherosclerosis posi-
tively and independently associated with cardiovascular 
risk in type 2 diabetes. In the current study, we not only 
found that patients with atherosclerosis had pronounc-
edly higher prevalence of CVEs and self-reported CVDs 
than those without atherosclerosis after controlling for 
age, sex, and duration of diabetes, but also explored that 
patients with atherosclerosis still had 4.742-fold for CVEs 
and 1.899-fold risk for self-reported CVDs after control-
ling for other potential confounders, compared with the 
patients without atherosclerosis.
Contrary to above results, some scholars have ques-
tioned the independent correlation between atheroscle-
rosis and CVEs, self-reported CVDs [24, 25]. Adeseun 
and colleagues [24] found that they were unable to detect 
any statistical difference regarding carotid plaque as a 
predictor of self-reported prevalent cardiovascular dis-
ease in the chronic kidney disease population. Several 
reasons could explain the difference. Firstly, self-report 
of cardiovascular disease may introduce misclassification 
bias. Moreover, different population, different race, and 
different measure methods may also contribute to the 
discrepancy. For example, population in study of Ade-
seun et  al. was comprised of participants with chronic 
kidney disease and a higher proportion of black [24], 
whereas our study population was consisted of diabetic 
patients largely with normal renal function and all from 
Asian.
More importantly, we found that the coexistence of 
carotid and lower extremity atherosclerosis further 
enhances the prevalence of both CVEs and self-reported 
CVDs, compared to either carotid or lower-limb ath-
erosclerosis independent of the other atherosclerosis 
indicators. In accordance with our findings, Davidsson 
et  al. [45] showed that 2.53-fold risk for cardiovascular 
events in concomitant presence of carotid and femo-
ral plaques was higher than 2.09-fold in carotid plaques 
and 1.99-fold in femoral plaques in Sweden middle-aged 
men during 10  years of follow-up. Furthermore, com-
pared with Davidson et  al. study [45], the association 
between atherosclerosis and cardiovascular events in our 
study was probably more precisely evaluated by meas-
uring “bilateral” carotid arteries and “bilateral” femo-
ral artery, while Davidson et  al. only measured carotid 
arteries and “one side” of femoral arteries. In addition, 
investigations regarding the relationship between the 
coexistence of carotid and lower-limb atherosclerosis and 
CVEs, self-reported CVDs remained scarce, top disputes 
were around the degree of relationship between carotid, 
femoral atherosclerosis and CVEs, self-reported CVDs. 
For example, some studies reported that the correlation 
between coronary and femoral artery atherosclerosis 
Fig. 3 Comparison of IMT in carotid and femoral among the 
three groups a Comparison of CIMT among the three groups after 
adjustment on age, sex and DD. The p value for group comparison 
was <0.001. b Comparison of FIMT among the three groups after 
adjustment on age, sex and DD. The p value for group comparison 
was <0.001
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were slightly weaker as compared to the relationship 
between carotid and coronary arteries, although carotid 
atherosclerosis and lower limb atherosclerosis are strong 
predictors of cardiovascular diseases [46–48]. Contrary 
to this, Sosnowski et al. [49] found that the femoral ath-
erosclerotic lesions were more informative than carotid 
atherosclerotic lesions in risk estimations for the extent 
and severity of coronary artery disease after controlling 
on traditional cardiovascular risk factors for 410 per-
form coronary angiography. The discordant results may 
be explained below: firstly, the Angina Prognosis Study 
[22]  indicated that plaques in the carotid artery were 
related to cardiovascular death or non-fatal myocardial 
infarction, whereas plaques in the femoral artery were 
related to revascularization after adjustment for a wide 
variety of traditional cardiovascular risk factors. Moreo-
ver, different factors such as local rheological conditions, 
vessels’ structure and stiffness influenced atherosclerosis 
development in the carotid and femoral arteries [50–52], 
and different measure methods were also adopted in 
above studies. For example, lower-extremity atheroscle-
rosis was reflected by the ankle-arm index in the Rot-
terdam Study while lower-limb ultrasound was used by 
us and Sosnowski et  al. [49], which could contribute to 
the inconsistencies among these studies. Base on this, 
we applied the combination of carotid and lower-limb 
ultrasound to assess the risk of CVEs and self-reported 
CVDs. Our results strongly indicated that patients 
Fig. 4 Comparison of the prevalence of CCBVEs and self‑reported CCBVDs among the three groups a Comparison of the prevalence of CVEs 
among the three groups after adjustment on age, sex and DD. The p value for group comparison was <0.001. b Comparison of the prevalence of 
CBVEs among the three groups after adjustment on age, sex and DD. The p value for group comparison was <0.001. c Comparison of the preva‑
lence of CCBVEs among the three groups after adjustment on age and sex. The p value for group comparison was <0.001. d Comparison of the 
prevalence of CVDs among the three groups after adjustment on age, sex and DD. The p value for group comparison was <0.001. e Comparison of 
the prevalence of CBVDs among the three groups after adjustment on age, sex and DD. The p value for group comparison was <0.001. f Compari‑
son of the prevalence of CCBVDs among the three groups after adjustment on age, sex and DD. The p value for group comparison was <0.001
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with the coexistence of carotid and lower extremity 
atherosclerosis had prominently higher risk for both 
CVEs and self-reported CVDs than those with either 
carotid or lower-limb atherosclerosis and those without 
atherosclerosis.
Currently, studies regarding the association with ath-
erosclerosis and CBVEs, self-reported CBVDs mainly 
centered on the relationship of plaque morphologic 
abnormalities, such as irregular surface and hypo-
echoic characteristics, and CBVEs [53–55]. For exam-
ple, Mathiesen et al. [56] showed that echolucent carotid 
plaques with a higher content of lipid and hemorrhage 
are associated with increased risk for CBVEs in subjects 
with carotid stenosis. Many studies have also demon-
strated MRI, rather than B-mode ultrasound, is able to 
distinguish plaque tissue characteristics and even quantify 
Table 2 Associations between carotid, lower-limb atherosclerosis and CVEs, CBVEs, CCBVEs
Model I: Adjusted for age, sex, smoking, alcohol, DD, MetS, hypertension and CKD
Model II: Adjusted for age, sex, smoking, alcohol, DD, MetS, hypertension, CKD, BMI, WHR, SBP and DBP
Model III: Adjusted for age, sex, smoking, alcohol, DD, MetS, hypertension, CKD, BMI, WHR, SBP, DBP, FPG, 2h PPG, HbA1c, CRP, FCP, 2h C-P, SCr, SUA, TG, TC, HDL-C and 
LDL-C
ORs (95 % CI) p value 
for trend
Without AS With either carotid  
or lower limb AS
With both carotid  
and lower limb AS
CVEs
 Model I 1 (ref ) 6.405 (1.484–27.651) 13.841 (3.322–57.677) <0.001
 Model II 1 (ref ) 6.090 (1.405–26.399) 13.302 (3.183–55.589) <0.001
 Model III 1 (ref ) 4.742 (1.050–21.411) 11.306 (2.602–49.129) <0.001
CBVEs
 Model I 1 (ref ) 1.429 (0.869–2.350) 2.218 (1.351–3.642) 0.001
 Model II 1 (ref ) 1.401 (0.833–2.356) 2.169 (1.290–3.645) 0.002
 Model III 1 (ref ) 1.389 (0.780–2.475) 2.092 (1.1710–3.738) 0.011
CCBVEs
 Model I 1 (ref ) 1.690 (1.052–2.714) 2.708 (1.681–4.362) <0.001
 Model II 1 (ref ) 1.685 (1.030–2.756) 2.749 (1.675–4.510) <0.001
 Model III 1 (ref ) 1.724 (1.001–2.966) 2.869 (1.660–4.960) <0.001
Table 3 Associations between carotid, lower-limb atherosclerosis and self-reported CVDs, CBVDs, CCBVDs
Model I: Adjusted for age, sex, smoking, alcohol, DD, MetS, hypertension and CKD
Model II: Adjusted for age, sex, smoking, alcohol, DD, MetS, hypertension, CKD, BMI, WHR, SBP and DBP
Model III: Adjusted for age, sex, smoking, alcohol, DD, MetS, hypertension, CKD, BMI, WHR, SBP, DBP, FPG, 2h PPG, HbA1c, CRP, FCP, 2h C-P, SCr, SUA, TG, TC, HDL-C and 
LDL-C
ORs (95 % CI) p value 
for trend
Without AS With either carotid  
or lower limb AS
With both carotid  
and lower limb AS
CVDs
 Model I 1 (ref ) 1.839 (1.118–3.025) 2.305 (1.387–3.832) 0.005
 Model II 1 (ref ) 2.002 (1.189–3.371) 2.543 (1.492–4.333) 0.002
 Model III 1 (ref ) 1.899 (1.057–3.413) 2.667 (1.467–4.847) 0.003
CBVDs
 Model I 1 (ref ) 1.515 (0.949–2.418) 2.123 (1.327–3.397) 0.002
 Model II 1 (ref ) 1.472 (0.905–2.396) 2.077 (1.272–3.389) 0.004
 Model III 1 (ref ) 1.582 (0.920–2.721) 2.114 (1.220–3.661) 0.017
CCBVDs
 Model I 1 (ref ) 1.587 (1.103–2.283) 2.023 (1.394–2.936) 0.001
 Model II 1 (ref ) 1.597 (1.093–2.333) 2.029 (1.376–2.993) 0.001
 Model III 1 (ref ) 1.705 (1.115–2.605) 2.147 (1.388–3.320) 0.002
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plaque components [57–59]. However, in comparison 
with B-mode ultrasound, MRI also has its disadvantage 
like higher price, costs longer time, and not available for 
everyone especially persons with metallic foreign body or 
pacemaker, so carotid MRI merely used as patients with 
carotid diseases especially carotid stenosis at present 
[53, 60, 61]. Therefore, in our current study, we inves-
tigated the association with the presence of plaques and 
CBVEs, CBVDs via both carotid and lower limb artery 
ultrasounds. And our results demonstrated that plaque 
occurrence in either carotid or lower limb arteries was 
not significantly associated with an increased risk of both 
CBVEs and self-reported CBVDs, consistent with Leng 
et al. [43]. Most importantly, to our great surprise, patients 
with the coexistence of carotid and lower extremity ath-
erosclerosis had 2.092-fold for CBVEs and 2.114-fold risk 
for self-reported CBVDs relative to the patients without 
atherosclerosis even after adjusting for various risk fac-
tors. Our above results intensely indicated that combined 
application of carotid and lower limb ultrasound exami-
nations to determine plaque is helpful to risk evaluation 
and prediction of both CBVEs and self-reported CBVDs 
in patients with type 2 diabetes.
Finally, we comprehensively assessed the relation of 
atherosclerosis and CCBVEs, self-reported CCBVDs in 
patients with type 2 diabetes. Our study displayed that 
not only either carotid or lower limb atherosclerosis 
was obviously related to increase cardio-cerebrovascular 
risks in type 2 diabetes, but also the concomitant pres-
ence of carotid and lower extremity atherosclerosis can 
further increase cardio-cerebrovascular risks in patients 
with type 2 diabetes. The above results indicated that 
clinicians could carry out drug intervention to prevent 
CCBVEs, self-reported CCBVDs for patients by referring 
to plaque conditions in practice.
To the best of our knowledge, this is the first time to 
systematically investigate the relationship between the 
concomitant carotid and lower-limb atherosclerosis 
and CCBVEs, self-reported CCBVDs with a large sam-
ple in Chinese patients with type 2 diabetes. Our results 
strongly indicated that patients with the coexistence of 
carotid and lower extremity atherosclerosis had promi-
nently higher risk for both CCBVEs and self-reported 
CCBVDs than those with either carotid or lower-limb 
atherosclerosis and those without atherosclerosis, which 
suggested that the combination with carotid and lower 
limb ultrasound should be a better method for the 
detection of atherosclerosis to predict the probability of 
CCBVEs and self-reported CCBVDs.
Limitations
Our study has important clinical implications on early 
detection of cardiovascular and cerebrovascular risks in 
patients with type 2 diabetes. However, there were sev-
eral limitations in our study. Firstly, our current study 
performed a single center cross-sectional study even 
after adjustment analysis, but some unmeasured hidden 
biases may still exist and thus we will do further research 
in our prospective studies to verify above results. Sec-
ondly, patients in our study were hospitalized type 2 
diabetes, and thus our current results may not be avail-
able to the general. Thirdly, CVDs, CBVDs and CCBVDs 
were mainly relied on the patient’s self-report, which 
may more or less introduce misclassification bias, so we 
strictly defined CVEs, CBVEs and CCBVEs in our study. 
Fourthly, we did not evaluate the impact of medical inter-
vention on CCBVEs and CCBVDs.
Conclusions
Either carotid or lower limb atherosclerosis was obvi-
ously related to increased cardiovascular and cerebrovas-
cular risks in type 2 diabetes. The concomitant presence 
of carotid and lower extremity atherosclerosis further 
increases cardiovascular and cerebrovascular risks in 
patients with type 2 diabetes. Therefore, in clinical prac-
tice, combined application of carotid and lower extremity 
arterial ultrasound should be advocated to identify those 
subjects with high cardiovascular and cerebrovascular 
risks.
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